SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from BeOne Medicines Ltd. (ONC, BEIGF) (CIK 0001651308) (ONC) — Feb 1, 2016

BeOne Medicines Ltd. (ONC, BEIGF) (CIK 0001651308)
Date: Feb. 1, 2016 · CIK: 0001651308 · Accession: 0001193805-16-002319

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-207459, 333-209044

Date
February 1, 2016
Author
Vice President
Form
CORRESP
Company
BeOne Medicines Ltd. (ONC, BEIGF) (CIK 0001651308)

Letter

Via EDGAR and Telecopier Securities and Exchange Commission Attention: Division of International Corporate Finance Fax: (202) 772-9207 Re: BeiGene, Ltd. Registration Statement on Form F-6 (Registration No.: 333-209044)

Dear Mr. Dudek:

Citibank N.A., as depositary (the “Depositary”) and acting solely on behalf of the legal entity created by the Form of Deposit Agreement, by and among the Depositary, BeiGene, Ltd., an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands (the “Company”), and all Holders and Beneficial Owners of American Depositary Shares issued thereunder representing ordinary shares, par value of US$0.0001 per share, of the Company, hereby requests that the effectiveness of Registration Statement on Form F-6 (Registration No.: 333- 209044) be accelerated to coincide with the accelerated effectiveness of the Company’s Registration Statement on Form S-1 (File No.: 333-207459).

Please call me at (212) 816-7937 if you have any questions.

Very truly yours,
CITIBANK, N.A.

Show Raw Text
CORRESP
1
filename1.htm

    Unassociated Document

[CITIBANK LETTERHEAD]

February 1, 2016

Via EDGAR and Telecopier

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C.  20549

Attention:

Paul Dudek, Esq

Division of International Corporate Finance

Fax:  (202) 772-9207

Re:

BeiGene, Ltd.

Registration Statement on Form F-6 (Registration No.:  333-209044)

Dear Mr. Dudek:

Citibank N.A., as depositary (the “Depositary”) and acting solely on behalf of the legal entity created by the Form of Deposit Agreement, by and among the Depositary, BeiGene, Ltd., an exempted company with limited liability incorporated and existing under the laws of the Cayman Islands (the “Company”), and all Holders and Beneficial Owners of American Depositary Shares issued thereunder representing ordinary shares, par value of US$0.0001 per share, of the Company, hereby requests that the effectiveness of Registration Statement on Form F-6 (Registration No.:  333- 209044) be accelerated to coincide with the accelerated effectiveness of the Company’s Registration Statement on Form S-1 (File No.: 333-207459).

Please call me at (212) 816-7937 if you have any questions.

Very truly yours,

CITIBANK, N.A.

By:

/s/ Leslie Deluca

Name:

Leslie Deluca

Title:
Vice President

cc:           Herman H. Raspé, Esq. (Patterson Belknap Webb & Tyler LLP)